Latest AI Startup Funding Rounds
Funding for companies building AI models, tools and applications. Explore the products, customers and businesses attracting capital.
- Rounds
- 2,254 Jan 1 – Oct 6, 2026
- Disclosed funding
- $192.7B 1929 disclosed amounts
- Median round
- $15M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| SP Develops next-generation peptide radioligand therapies for cancer | $18M | Series A | AI, Biotech | United States | Investors | |
| PS ProSomnus Sleep TechnologiesCompany profile Provides non-CPAP alternative for Obstructive Sleep Apnea treatment Provides non-CPAP alternative for Obstructive Sleep Apnea treatment | $38M | StrategicUndisclosed | AI, Healthtech | United States | Investors | |
| O OnshoreCompany profile Builds AI-powered platform to help businesses claim and defend tax incentives like R&D credits with automation and expert review Builds AI-powered platform to help businesses claim and defend tax incentives like R&D credits with automation and expert review | $31M | Series B | AI, Fintech | United States | Investors | |
| V Provides infrastructure platform powering America's modern savings economy | $385M | Series ESeries C+ | AI, Fintech | United States | Investors | |
| CS Cogent SecurityCompany profile Builds autonomous AI agents to automate vulnerability remediation for security teams Builds autonomous AI agents to automate vulnerability remediation for security teams | $42M | Series A | AI, Cybersecurity | United States | Investors | |
| P Pharmacelera uses quantum-mechanics methods and AI in drug discovery. | €6M | Growth | AI, Biotech | Spain | Investors | |
| SB Sift BiosciencesCompany profile Develops next-generation peptide immunotherapy platform using AI metagenomics and high-throughput profiling to engage memory T cells for cancer and autoimmune diseases Develops next-generation peptide immunotherapy platform using AI metagenomics and high-throughput profiling to engage memory T cells for cancer and autoimmune diseases | $3.7M | Pre-SeedPre-seed | AI, Biotech | United States | Investors | |
| A Provides AI-native operating system for financial services firms | $35M | Series A | AI, Fintech | United States | Investors | |
| Z Builds AI agent for software reverse engineering | Undisclosed | Pre-SeedPre-seed | AI, Cybersecurity | Israel | Investors | |
| RH Rainfall HealthCompany profile AI software that helps hospitals manage compliance and reimbursement programs AI software that helps hospitals manage compliance and reimbursement programs | $15M | Series A | AI, Healthtech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Halluminate, ByteAsk, Firecrawl
104rounds2led - 2General Catalyst
Melius, General Intuition, Sol
74rounds5led - 3Andreessen Horowitz (a16z)
Ghost, Conway Research, EliseAI
72rounds11led - 4Lightspeed
RobCo, Enveda, Snorkel AI
63rounds4led - 5Accel
Arivihan, Ando, Ema
50rounds4led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.